Trials in Progress: A Phase I/II Study of Venetoclax and Lintuzumab-Ac225 in Patients with Refractory or Relapsed AML Article

Web of Science: 000564055100112

Cited authors

  • Hegazi, Mohamed; Finn, Laura; Roboz, Gail; Harpel, John; Schiller, Gary

Authors

Publication date

  • 2020

Published in

Category

International Standard Serial Number (ISSN)

  • 2152-2650

Start page

  • S196

End page

  • S196

Volume

  • 20